title: CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue.
abstract: Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) that are characterized by chronic intestinal inflammation and a constant influx of leukocytes mediated by pro-inflammatory cytokines and chemokines. The intestinal expression of the CXCR1-binding chemokines IL-8/CXCL8 and GCP-2/CXCL6 and the participation of immunocompetent cells in IBD were evaluated. IL-8 production by peripheral blood mononuclear cells (PBMC) from IBD patients, stimulated with endotoxin, plant lectin or double-stranded RNA, was significantly lowered in patients with CD, but not in UC patients or healthy subjects. The reduced chemokine production by PBMC from IBD patients was both IL-8 and CD specific, but not inducer dependent. In serum, most chemokines remained undetectable, while the levels of those that were measurable remained unaltered in IBD patients. GCP-2, but not ENA-78/CXCL5, nor IL-8, were highly expressed by endothelial cells in inflamed intestinal tissue of IBD patients. In contrast, stimulated endothelial cell cultures produced more IL-8 than GCP-2. The selective GCP-2 staining of endothelial cells at sites of ulcerations suggests that GCP-2, despite its low production capacity in vitro, plays a role in IBD that is different from that of structurally (ENA-78) and functionally (IL-8) related ELR(+) CXC chemokines. Thus, the chemokine network shows complementarity rather than redundancy.
authors.affiliation: Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium.
authors.forename: Klara
authors.initials: K
authors.lastname: Gijsbers
authors.forename: Gert
authors.initials: G
authors.lastname: Van Assche
authors.forename: Sofie
authors.initials: S
authors.lastname: Joossens
authors.forename: Sofie
authors.initials: S
authors.lastname: Struyf
authors.forename: Paul
authors.initials: P
authors.lastname: Proost
authors.forename: Paul
authors.initials: P
authors.lastname: Rutgeerts
authors.forename: Karel
authors.initials: K
authors.lastname: Geboes
authors.forename: Jo
authors.initials: J
authors.lastname: Van Damme
mesh_terms: D054427:Chemokine CXCL6; D019743:Chemokines, CXC / Q000096:biosynthesis / Q000378:metabolism*; D003424:Crohn Disease / Q000097:blood / Q000378:metabolism* / Q000473:pathology; D015536:Down-Regulation; D042783:Endothelial Cells / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007150:Immunohistochemistry; D007249:Inflammation / Q000097:blood / Q000378:metabolism; D036341:Intercellular Signaling Peptides and Proteins / Q000096:biosynthesis / Q000378:metabolism; D016209:Interleukin-8 / Q000096:biosynthesis / Q000378:metabolism*; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000473:pathology; D007962:Leukocytes / Q000378:metabolism*; D023062:Receptors, Interleukin-8A / Q000096:biosynthesis / Q000378:metabolism*
chemical_list: C515503:CXCL6 protein, human; D054427:Chemokine CXCL6; D019743:Chemokines, CXC; D036341:Intercellular Signaling Peptides and Proteins; D016209:Interleukin-8; D023062:Receptors, Interleukin-8A